RETATRUTIDE ONE 10 mg

RETATRUTIDE ONE is a 10 mg peptide formulation developed by OMEGA ONE Pharmaceuticals, with a focus on purity, consistency, and stability for specialized research applications.

Product Overview

Retatrutide ONE represents a new generation of compounds attracting considerable interest in metabolic research because of its activity across GLP-1, GIP, and glucagon receptors. RETATRUTIDE ONE 10 mg brings this innovative triple-agonist molecule to the OMEGA ONE portfolio in a professional presentation for advanced research into metabolic signaling, energy balance, and body-weight regulation.

Characteristics

• Active Compound: Retatrutide
• Strength: 10 mg
• Form: Lyophilized peptide
• Mechanism Studied: Triple GLP-1, GIP, and glucagon receptor agonist
• Research Focus: Investigated in clinical research involving appetite regulation, glucose metabolism, energy expenditure, metabolic signaling, and body-weight management
• Quality: High-purity formulation designed for consistency and stability
• Brand: OMEGA ONE Pharmaceuticals
• Storage: Store according to product specifications; refrigeration is generally required after reconstitution
• Professional Use: Intended for specialized applications in accordance with applicable regulations

Presentation
1 vial of Lyophilized Powder
1 vial of Diluent – 3 mL